BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26952843)

  • 21. miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia.
    Liu X; Zou L; Zhu L; Zhang H; Du C; Li Z; Gao C; Zhao X; Bao S; Zheng H
    Leuk Res; 2012 Sep; 36(9):1098-104. PubMed ID: 22677230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
    Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
    Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity.
    Siddiquee K; Zhang S; Guida WC; Blaskovich MA; Greedy B; Lawrence HR; Yip ML; Jove R; McLaughlin MM; Lawrence NJ; Sebti SM; Turkson J
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7391-6. PubMed ID: 17463090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and
    Oleksak P; Psotka M; Vancurova M; Sapega O; Bieblova J; Reinis M; Rysanek D; Mikyskova R; Chalupova K; Malinak D; Svobodova J; Andrys R; Rehulkova H; Skopek V; Ngoc Lam P; Bartek J; Hodny Z; Musilek K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):410-424. PubMed ID: 33440995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
    Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
    Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
    Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
    Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
    Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma.
    Chen W; Shen X; Xia X; Xu G; Ma T; Bai X; Liang T
    Liver Int; 2012 Jan; 32(1):70-7. PubMed ID: 22098470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3.
    Lanuti P; Bertagnolo V; Pierdomenico L; Bascelli A; Santavenere E; Alinari L; Capitani S; Miscia S; Marchisio M
    Cell Res; 2009 Sep; 19(9):1079-89. PubMed ID: 19564891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
    Xiao R; Gan M; Jiang T
    Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
    Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
    Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia.
    Mansha M; Carlet M; Ploner C; Gruber G; Wasim M; Wiegers GJ; Rainer J; Geley S; Kofler R
    Leuk Res; 2010 Apr; 34(4):529-34. PubMed ID: 19631983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia.
    Uckun FM; Pitt J; Qazi S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):37-48. PubMed ID: 21070101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.